Skip to content

A randomized double-blind controlled study of Shuhe Granules in treating heart and kidney deficiency and Qi and blood disharmony syndrome of chronic insomnia disorder

A randomized, double-blind, controlled clinical study of Shuhe Granules in the treatment of chronic insomnia disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2023000013
Enrollment
Unknown
Registered
2023-05-26
Start date
2023-06-06
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

treatment group:Shuhe Granules
control group:placebo

Sponsors

Guangdong Provincial hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-70 (2) In line with Western medicine chronic insomnia diagnostic standards It is consistent with the diagnostic criteria of chronic insomnia in the new edition of International Classification of Sleep Disorders? formulated by the American Academy of Sleep Medicine (3) Consistent with the indications of Shuhe granules: Both of the following three a. sleep difficulty factor score of Pittsburgh Sleep Quality Index =1 b. daytime function factor score of Pittsburgh Sleep Quality Index =1 c. Dizziness, palpitation, low menstrual volume, spontaneous sweating, fear of wind, cold limbs, white tongue, pale face, pale or reddish eyelids (symptoms =3/8). None of the following cannot appear at the same time a. The lower eyelid is completely red b. Warm hands c. Dry, stiff stool d. Thick and greasy or dry and rough moss e. Pulse ratio greater than 5.5 (4) Sign informed consent

Exclusion criteria

Exclusion criteria: 1.Preparing to become pregnant or during pregnancy or lactation; 2. Secondary insomnia caused by physical disease. For example: local pain, restless leg syndrome, sleep apnea syndrome, acute and chronic heart failure, chronic obstructive pulmonary disease, acute and chronic bronchitis, etc. 3. Secondary insomnia caused by mental disease. For example: Affective disorders, anxiety disorder, depression, schizophrenia, and any other serious mental disorders. 4. A Patient health questionnaire-9 (PHQ-9) score of 15 or higher; 5. A Generalized Anxiety Scale (GAD-7) score of 15 or higher 6. Use of medicine to treatment sleeping disorders in the past two week. 7.Participants in clinical trials of other drugs in the past 30 days;

Design outcomes

Primary

MeasureTime frame
Insomnia Severity Index;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index;Patient health questionnaire-9;polysomnography;Fatigue Severity Scale;Traditional Chinese Medicine Questionnaire of Quality of life on Insomnia disease;Generalized Anxiety Scale-7;

Countries

China

Contacts

Public ContactZhimin Yang

Guangdong Provincial Hospital of Traditional Chinese Medicine

yangyo@vip.tom.com13822296363

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026